89bio Inc (NASDAQ:ETNB)’s traded shares stood at 1.3 million during the last session, with the company’s beta value hitting 0.95. At the close of trading, the stock’s price was $11.31, to imply an increase of 0.98% or $0.11 in intraday trading. The ETNB share’s 52-week high remains $22.93, putting it -102.74% down since that peak but still an impressive 41.91% since price per share fell to its 52-week low of $6.57. The company has a valuation of $1.06B, with an average of 1.46 million shares in intraday trading volume over the past 10 days and average of 1.36 million shares over the past 3 months.
89bio Inc (NASDAQ:ETNB) trade information
After registering a 0.98% upside in the last session, 89bio Inc (ETNB) has traded red over the past five days. The stock hit a weekly high of 11.89, jumping 0.98% in its intraday price action. The 5-day price performance for the stock is -0.09%, and -3.66% over 30 days. With these gigs, the year-to-date price performance is 1.25%. Short interest in 89bio Inc (NASDAQ:ETNB) saw shorts transact 10.86 million shares and set a 7.98 days time to cover.
89bio Inc (ETNB) estimates and forecasts
Looking at statistics comparing 89bio Inc share performance against respective industry, we note that the company has underperformed competitors. 89bio Inc (ETNB) shares are -27.87% down over the last 6 months, with its year-to-date growth rate lower than industry average at -10.00% against 12.60%. Revenue is forecast to grow 14.80% this quarter before jumping 1.90% for the next one.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -11.24% for the past 5-year period. While 2024 is set for a -2.97% return in earnings, projections for the next 5 years are at 11.00% annually.
ETNB Dividends
89bio Inc has its next earnings report out between May 02 and May 06. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. 89bio Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
89bio Inc (NASDAQ:ETNB)’s Major holders
89bio Inc insiders hold 0.89% of total outstanding shares, with institutional holders owning 106.41% of the shares at 107.36% float percentage. In total, 106.41% institutions holds shares in the company, led by RA Capital Management, L.P.. As of Jun 29, 2023, the company held over 11.42 million shares (or 15.13% of shares), all amounting to roughly $216.35 million.
The next major institution holding the largest number of shares is Blackrock Inc. with 4.65 million shares, or about 6.16% of shares outstanding. As of the market price on Jun 29, 2023, these shares were worth $88.12 million.
We also have SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the 89bio Inc (ETNB) shares. Going by data provided on Aug 30, 2023, SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF holds roughly 3.39 million shares. This is just over 4.49% of the total shares, with a market valuation of $58.03 million. Data from the same date shows that the other fund manager holds a little less at 1.82 million, or 2.41% of the shares, all valued at about 34.42 million.
